2020
DOI: 10.1007/978-3-030-58592-1_27
|View full text |Cite
|
Sign up to set email alerts
|

Co-heterogeneous and Adaptive Segmentation from Multi-source and Multi-phase CT Imaging Data: A Study on Pathological Liver and Lesion Segmentation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
4
1

Relationship

4
5

Authors

Journals

citations
Cited by 31 publications
(19 citation statements)
references
References 37 publications
0
19
0
Order By: Relevance
“…This dual-PHNN baseline is very strong on our public data, achieving a DSC score of 96.9% on the D s test set. For discriminator, we use a 3D version of a popular architecture [16] using atrous convolution, which has proved a useful discriminator for liver masks [21]. We do not use the multi-level discriminator variant proposed by Tsai et al [26], as its added complexity does not seem to result in noticeable improvements for liver-based PADA [21].…”
Section: User-guided Domain Adaptationmentioning
confidence: 99%
See 1 more Smart Citation
“…This dual-PHNN baseline is very strong on our public data, achieving a DSC score of 96.9% on the D s test set. For discriminator, we use a 3D version of a popular architecture [16] using atrous convolution, which has proved a useful discriminator for liver masks [21]. We do not use the multi-level discriminator variant proposed by Tsai et al [26], as its added complexity does not seem to result in noticeable improvements for liver-based PADA [21].…”
Section: User-guided Domain Adaptationmentioning
confidence: 99%
“…For discriminator, we use a 3D version of a popular architecture [16] using atrous convolution, which has proved a useful discriminator for liver masks [21]. We do not use the multi-level discriminator variant proposed by Tsai et al [26], as its added complexity does not seem to result in noticeable improvements for liver-based PADA [21]. Specific details on the choice of hyper parameters are listed in the supplementary material.…”
Section: User-guided Domain Adaptationmentioning
confidence: 99%
“…While there are efforts towards SSL for landmark localization [5,18], they are based off of convolutional neural network (CNN)-only approaches, rather than the stateof-the-art GCN-based DAG. Some other prominent SSL successes in medical imaging have also been reported, such as for segmentation [2,15] and abnormality detection [22], but these are also CNN-based. Most other SSL methods are mainly developed for natural image classification tasks [7,8,1,19], which likewise do not address GCN-based landmark localization.…”
Section: Introductionmentioning
confidence: 98%
“…Many efforts have been developed for automating lesion size measurement. Specifically, deep convolutional neural networks are successfully applied to segment tumors in brain [12], lung [31,16,39], pancreas [41,37], liver [8,19,7,22,28,36], enlarged lymph node [20,40], etc. Most of these approaches are specifically designed for a certain lesion type, however, an effective and efficient lesion size measurement tool should be able to handle a variety of lesions in practice [3,26,1,29].…”
Section: Introductionmentioning
confidence: 99%